Tissue Repair (ASX:TRP) Stock Based Compensation: A$0.00 Mil (TTM As of Dec. 2025)


ASX:TRP Tissue Repair Ltd ASX:TRP
26 GF Score
Price A$0.11
View Full Analysis

What is Tissue Repair Stock Based Compensation?

Tissue Repair ASX:TRP 26 Stock Based Compensation is A$0.00 Mil as of Dec. 2025. GuruFocus rates ASX:TRP with a GF Score™ of 26/100.

Tissue Repair's Stock Based Compensation for the six months ended in Dec. 2025 was A$0.00 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.00 Mil.


Tissue Repair Stock Based Compensation Related Terms


Tissue Repair Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Tissue Repair's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tissue Repair Stock Based Compensation Chart

Tissue Repair Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
Stock Based Compensation
0.00 0.00 0.00 0.00 0.00

Tissue Repair Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ASX:TRP
26GF Score
Tissue Repair Ltd ASX:TRP
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tissue Repair Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

What does a Stock Based Compensation of A$0.00 Mil mean?
Tissue Repair (ASX:TRP) has a Stock Based Compensation of A$0.00 Mil as of Dec. 2025. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Tissue Repair and its competitors.
Is Tissue Repair's Stock Based Compensation too high?
Tissue Repair's current Stock Based Compensation is A$0.00 Mil. Overall, Tissue Repair has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Tissue Repair's Stock Based Compensation compare to VRTX and REGN?
Tissue Repair's Stock Based Compensation of A$0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Biotechnology company?
A good Stock Based Compensation depends on the Biotechnology industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Tissue Repair and its competitors. Tissue Repair's current Stock Based Compensation is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tissue Repair stock overvalued right now?
Tissue Repair (ASX:TRP) has a current Stock Based Compensation of A$0.00 Mil. The current Stock Based Compensation is A$0.00 Mil. Tissue Repair's overall GF Score™ is 26/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Tissue Repair (ASX:TRP), the current Stock Based Compensation is A$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Tissue Repair Business Description

Address 821 Pacific Highway, Tower A, Level 9, The Zenith, Chatswood, NSW, AUS, 2067
Tissue Repair Ltd is a clinical-stage biopharmaceutical company engaged in development of wound healing products for chronic wounds and the aftercare of cosmetic procedures, with the potential for further development of related technologies.
26GF Score

Get the complete analysis for ASX:TRP

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.11
Price